Budesonide for Maintenance Treatment of Collagenous Colitis

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Technische Universität Dresden
• Collaborator: AstraZeneca
• Treatments: Budesonide

Criteria

Inclusion Criteria:

• collagenous colitis

• diarrhea

• written informed consent

Exclusion Criteria:

• infectious causes for diarrhea

• other inflammatory bowel diseases

• history of colonic surgery

• celiac disease

• malignancies

• severe concomitant diseases

• use of budesonide, steroids, mesalazine within the previous 2 weeks

• known intolerance to budesonide

• history of lack of response to budesonide

• pregnancy,lactation

• drug and/or alcohol abuse

• lack of compliance